In the wake of President Trump’s proposed ban of flavored vaping products, the NCIA is fighting for cannabis regulation. September 12, 2019 5 min read Opinions expressed by Entrepreneur contributors are their own. As information continues to surface of unfortunate incidents related to e-cigarettes and vaping — with more than 500 people falling ill and
In the wake of President Trump’s proposed ban of flavored vaping products, the NCIA is fighting for cannabis regulation.
5 min read
Opinions expressed by Entrepreneur contributors are their own.
As information continues to surface of unfortunate incidents related to e-cigarettes and vaping — with more than 500 people falling ill and six reported deaths — President Donald Trump stepped in to try and monitor the use of flavored e-cigarettes, announcing a proposal to ban thousands of flavors used in nicotine vaping products.
While addressing the media today, President Trump had this to say when discussing the proposed ban:
“It’s very new and potentially very bad. There have been deaths and there have been a lot of other problems. People think it’s an easy solution to cigarettes, but turns out that it has its own difficulties. Not only is it a problem overall, but really specifically with respect to children.”
So what does a ban on nicotine vaping products mean for the millions of people who vape CBD? That’s still up for debate, but, according to MJ Biz, it could have broader ramifications. Given today’s news, the National Cannabis Industry Association (NCIA) is being proactive given the President’s announcement today, staking its claim to challenge Congress to regulate cannabis, with advocates citing prohibition as the main driver of illicit market products linked to most cases.
In a statement from the Executive Director of NCIA, Aaron Smith, he cited remorse for the unfortunate illnesses and deaths relating to vaping, but was quick to challenge Congress in changing policy relating to the current federal laws, which, in his words, “interfere with research, prevent federal regulatory agencies from establishing safety guidelines, discourage states from regulating cannabis, and make it more difficult for state-legal cannabis businesses to displace the illicit market.”
Here’s part of the statement from Smith in reaction to the Trump Administration’s proposal:
“These unfortunate illnesses and deaths are yet another terrible, and largely avoidable, consequence of failed prohibition policies.”
“These policies are directly bolstering the markets for untested and potentially dangerous illicit products. The fact that so few of these cases have so far reported any link whatsoever to the legal cannabis market is a testament to the effectiveness of state regulators and licensed businesses at ensuring product reliability. As an industry, however, we view it as our duty to make sure whatever is causing these illnesses is not replicated in legal products and to work toward enacting regulations that can prevent similar public health issues from occurring in the future. The legal cannabis industry is paying very close attention to any new information provided by medical authorities regarding these cases.
“It is now the responsibility of Congress to end prohibition and regulate cannabis without delay. By removing cannabis from the schedule of controlled substances and instituting a clear regulatory framework through existing agencies, the federal government can provide helpful guidance to states that have or wish to establish regulated cannabis control systems while helping put irresponsible illicit market producers out of business for good.
“We are deeply saddened by this situation and sincerely hope the specific causes are determined as soon as possible to help avoid further suffering. We stand ready to work with Congress and federal regulators on the long-term solution to this problem, which is replacing prohibition with sound regulations.”
Additionally, the National Cannabis Industry Association is making the following recommendations to Congress in order to prevent further illnesses and/or deaths from vaping, hoping that federal regulation of cannabis will eliminate these so-called “irresponsible illicit market producers.”
- Congress is urged to immediately remove cannabis from the Controlled Substances Act and begin to sensibly regulate this substance in a manner similar to alcohol and other consumables, and to make funds immediately available to state medical authorities to investigate these cases.
- Licensed vape cartridge producers are encouraged to halt the use, if any, of additive thickening agents until more data is available.
- Given the preliminary reported association of some illness cases with Vitamin E acetate, any licensed producer that has included this additive in recent vape product batches is strongly encouraged to issue a voluntary recall of those products.
- Licensed cannabis retailers are encouraged to take steps to ensure none of their available vape cartridge inventories have been sourced from a producer that uses Vitamin E acetate.
- Cannabis vape cartridge consumers are urged to immediately cease the use of any product obtained from the illicit market and to limit any future purchases of vape cartridges and other cannabis products to state-licensed, regulated businesses.
In addition to Smith’s statements above, we also spoke with Morgan Fox, the Media Relations Director for the NCIA, who offered up this when discussing the President’s proposed ban.
“Nicotine and cannabis vaporizer products are separate and distinct issues, and we look forward to working with the FDA and other agencies to develop effective regulations when Congress makes it possible by ending prohibition.”
The NCIA is fighting for federal regulation of cannabis, with such a move aimed to decrease or eliminate available products on the illicit market where irresponsible producers don’t care about product safety or age controls. Time will tell if the outcry will be successful.